A multi-center, double-masked study of the safety and efficacy of DuoTrav APS compared to DuoTrav in patients with open-angle glaucoma or ocular hypertension The primary objective of this study is to compare the efficacy and safety of DuoTrav APS to DuoTrav, both dosed once-daily in the morning, in patients with open angle glaucoma or ocular hypertension.

• Pays Aucun
• Organes Aucun
• Spécialités Aucune

Travoprost 0.004% in Pediatric Glaucoma Patients The primary objective of this study is to demonstrate that the IOP-lowering efficacy of Travoprost Ophthalmic Solution, 0.004% (preserved with POLYQUAD) is noninferior to Timolol Ophthalmic Solution (...

• Pays Aucun
• Organes Aucun
• Spécialités Aucune

A Six-Week, multicenter, randomized, double-masked study to evaluate the efficacy and safety of dosing once-daily Travoprost/Timolol in the morning vs. twice-daily Dorzolamide/Timolol in patients with open-angle glaucoma or ocular hypertension The primary objective of this study is to compare the IOP-lowering efficacy and safety of dosing of Travoprost 0.004%/Timolol 0.5% Ophthalmic Solution (once-daily morning dosing) vs. Dorzolamide 2%/Ti...

• Pays Aucun
• Organes Aucun
• Spécialités Aucune

An Evaluation of Patient Reported Outcomes and Ocular Surface Health in Patients Using Travoprost APS Eye Drops Solution Versus XALATAN Eye Drops Solution The primary statistical objective is to describe differences between Travoprost APS and XALATAN® for mean NEI VFQ-25 composite (Visual Function) score at the end of the three-month treatment period in...

• Pays Aucun
• Organes Aucun
• Spécialités Aucune

Patient Preference Comparison of Azarga versus Cosopt, in Patients with Open-Angled Glaucoma or Ocular Hypertension The objective of this study is to assess patient preference of AZARGA® compared to COSOPT® after one week instillation of each study medication is administered to both eyes, in patients with open-angl...

• Pays Aucun
• Organes Aucun
• Spécialités Aucune

Ocriplasmin for Vitreomacular Traction/Symptomatic Vitreomacular Adhesion To observe the anatomical and functional outcomes of ocriplasmin over a 6-month follow-up period

• Pays Aucun
• Organes Aucun
• Spécialités Aucune

A twelve-month, multicenter, double-masked study of Travoprost / Brinzolamide fixed combination QD AM and Travoprost / Brinzolamide fixed combination QD PM versus COSOPT BID in patients with open-angle glaucoma or ocular hypertension The primary objective of this study is to compare the IOP-lowering efficacy and the safety over 12 months, of morning or evening instillations of Travoprost / Brinzolamide versus COSOPT dosed in the m...

• Pays Aucun
• Organes Aucun
• Spécialités Aucune

24-hour IOP control with Travoprost / Brinzolamide fixed combination once-daily (QD)in the evening vs TRAVATAN To evaluate the effect on mean nocturnal IOP of the fixed combination Travoprost/Brinzolamide dosed once-daily in the evening versus TRAVATAN dosed once-daily in the evening, in patients with open-...

• Pays Aucun
• Organes Aucun
• Spécialités Aucune

A study to investigate the combined effect of Simbrinza with another eye medication on Glaucoma To demonstrate the additive IOP lowering effect of Brinzolamide 1%/Brimonidine 0.2% (dosed BID) when added to Travoprost 0.004%/Timolol 0.5% solution in subjects with open-angle glaucoma or ocular hyp...

• Pays Aucun
• Organes Aucun
• Spécialités Aucune

A Three-Month, Multicenter, Double-Masked Study Comparing the Safety and Efficacy of the Fixed Combination Travoprost + Brinzolamide Eye Drops, Suspension vs Travatan vs Azopt in Patients with Open-Angle Glaucoma or ocular Hypertension To compare the IOP lowering efficacy of morning or evening instillations of Travoprost / Brinzolamide, versus TRAVATAN dosed in the evening, versus AZOPT dosed in the morning and in the evening, in pa...

• Pays Aucun
• Organes Aucun
• Spécialités Aucune